Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
May 18, 2022 16:05 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, May 18, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and...
Sensus Healthcare First Quarter 2022 Financial Results Feature Revenue Growth of 237%
May 05, 2022 16:05 ET
|
Sensus Healthcare, Inc.
Diluted EPS from operations of $0.20 compare with $(0.07) in the year-ago quarter Affirms expectations for continued growth in the second quarter and full year profitability Conference call...
Sensus Healthcare to Host First Quarter 2022 Financial Results and Business Update Conference Call on May 5, 2022
April 21, 2022 08:00 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, April 21, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological...
Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
March 24, 2022 08:00 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla. , March 24, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Sensus Healthcare to Present at Two Investment Conferences in March
March 09, 2022 16:05 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla. , March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Sensus Healthcare Announces Share Repurchase Program
March 09, 2022 08:00 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
March 02, 2022 08:00 ET
|
Sensus Healthcare, Inc.
Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:...
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
February 10, 2022 16:05 ET
|
Sensus Healthcare, Inc.
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference...
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
January 31, 2022 16:05 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
January 26, 2022 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...